Press release
Preclinical CRO Market Size, Trends, Growth, Opportunities (2023-2030) | Icon plc, Syneos Health, and Charles River Laboratories
Preclinical CRO Market
Biotechnology and biopharmaceutical companies have increased their focus on outsourcing their R&D for new therapeutics to contract research organizations (CROs) for cost-effective and time-efficient research studies. Factors such as enhanced preclinical testing, decentralized studies, regulatory compliance, risk management, and cost reduction have fueled the outsourcing of research studies by healthcare companies and research institutes to preclinical CROs.
๐๐ถ๐๐ฐ๐ผ๐๐ฒ๐ฟ ๐ช๐ต๐ฎ๐ ๐ฌ๐ผ๐'๐ฟ๐ฒ ๐ ๐ถ๐๐๐ถ๐ป๐ด: ๐๐ฒ๐ ๐ฎ ๐๐ฟ๐ฒ๐ฒ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ (๐ฃ๐๐) ๐ฆ๐ฎ๐บ๐ฝ๐น๐ฒ: https://www.fortunebusinessinsights.com/enquiry/sample/preclinical-cro-market-106939
๐๐ฒ๐ ๐๐ป๐ฑ๐๐๐๐ฟ๐ ๐๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐
In December 2021, Laboratory Corporation of America Holdings acquired Toxikon Corporation. This strategic acquisition aims to enhance Labcorp's non-clinical development capabilities, allowing the company to deliver comprehensive preclinical solutions to its clients and further strengthen its leadership in the Preclinical CRO Market.
๐ง๐ผ๐ฝ ๐๐ผ๐บ๐ฝ๐ฎ๐ป๐ถ๐ฒ๐ ๐ถ๐ป ๐๐ต๐ฒ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐
โข Novotech (Australia)
โข Thermo Fisher Scientific Inc. (U.S.)
โข Medpace (U.S.)
โข Icon plc (Ireland)
โข Syneos Health (U.S.)
โข Laboratory Corporation of America (U.S.)
โข Eurofins Discovery (U.S.)
โข EVOTEC (Germany)
โข Charles River (U.S.)
โข WuXi AppTec (China)
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ฟ๐ถ๐๐ฒ๐ฟ๐ & ๐ฅ๐ฒ๐๐๐ฟ๐ฎ๐ถ๐ป๐๐
Market Drivers: The growth of the Preclinical CRO Market is fueled by increasing demand for advanced drug development solutions, the rising prevalence of chronic and complex diseases, and the growing need for outsourcing preclinical research to reduce costs and time-to-market. Additionally, advancements in preclinical technologies and the expansion of research in oncology significantly contribute to market growth.
Market Restraints: Challenges such as stringent regulatory requirements, high costs associated with preclinical research, and ethical concerns regarding animal testing may hinder market expansion. However, ongoing innovations and alternative testing methods are expected to mitigate these challenges in the future.
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐๐ผ๐๐ฒ๐ฟ๐ฎ๐ด๐ฒ
The market report comprehensively analyses the Preclinical CRO Market, including emerging trends, competitive dynamics, and segmentation by application and region. It offers valuable insights into how industry players are leveraging technological advancements to address evolving customer needs.
๐๐ผ๐ฟ ๐๐๐น๐น ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐๐ผ๐๐ฒ๐ฟ๐ฎ๐ด๐ฒ ๐ฉ๐ถ๐๐ถ๐: https://www.fortunebusinessinsights.com/preclinical-cro-market-106939
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐๐ฒ ๐๐ฎ๐ป๐ฑ๐๐ฐ๐ฎ๐ฝ๐ฒ
The competitive landscape of the Preclinical CRO Market is characterized by significant mergers, acquisitions, and partnerships. Leading companies such as Charles River, WuXi AppTec, and Labcorp are investing heavily in expanding their service portfolios to maintain a competitive edge. Emerging players are also focusing on niche segments to capture a share of the growing market.
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฆ๐ฒ๐ด๐บ๐ฒ๐ป๐๐
Leading Segment: By application, the oncology segment dominated the Preclinical CRO Market. The increasing prevalence of cancer worldwide and the rising demand for innovative oncology therapies are the primary drivers for this segment's growth.
Other Segments: Additional segments include cardiovascular diseases, neurological disorders, and infectious diseases, all contributing to the overall market expansion.
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฅ๐ฒ๐ด๐ถ๐ผ๐ป๐ฎ๐น ๐๐ป๐๐ถ๐ด๐ต๐๐
North America holds the largest share of the Preclinical CRO Market due to its robust pharmaceutical and biotechnology sectors, advanced research infrastructure, and significant investments in drug development. Europe follows closely, driven by increased R&D activities and supportive government policies. The Asia-Pacific region is emerging as a lucrative market due to cost advantages, skilled labour, and rising investments in preclinical research, particularly in countries like China and India.
๐๐๐๐๐ฟ๐ฒ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฆ๐ฐ๐ผ๐ฝ๐ฒ
The future of the Preclinical CRO Market is promising, with increasing adoption of artificial intelligence and automation in preclinical studies. These technologies enhance efficiency, accuracy, and speed, revolutionizing drug discovery. Moreover, the growing focus on personalized medicine and advancements in 3D cell culture models are expected to create new growth opportunities for market players. As demand for outsourcing preclinical research continues to rise, the market is poised for sustained expansion in the coming years.
For an in-depth analysis and detailed insights, visit the Preclinical CRO Market Report.
๐๐๐๐๐ผ๐บ๐ถ๐๐ฒ ๐ง๐ต๐ถ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐๐ฐ๐ฐ๐ผ๐ฟ๐ฑ๐ถ๐ป๐ด ๐ง๐ผ ๐ฌ๐ผ๐๐ฟ ๐๐ผ๐ป๐๐ฒ๐ป๐ถ๐ฒ๐ป๐ฐ๐ฒ: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/preclinical-cro-market-106939
๐๐ผ๐ป๐๐ฎ๐ฐ๐ ๐จ๐:
Fortune Business Insightsโข Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.:+1 833 909 2966 (Toll-Free)
U.K.: +44 808 502 0280 (Toll-Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Fortune Business Insightsโข offers expert corporate analysis and accurate data, helping organizations make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preclinical CRO Market Size, Trends, Growth, Opportunities (2023-2030) | Icon plc, Syneos Health, and Charles River Laboratories here
News-ID: 3786579 • Views: โฆ
More Releases from Fortune Business Insights
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop โฆ
Global Renewable Energy Market Overview
The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected toโฆ
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview
The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion byโฆ
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow โฆ
Brief Market Overview:
The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%.
These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growthโฆ
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by โฆ
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period.
The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollutionโฆ
More Releases for CRO
Global Veterinary CRO & CDMO Market Size & Trends
According to a new market research report published by Global Market Estimates, the global veterinary CRO & CDMO market is expected to grow at a CAGR of 9.1% from 2023 to 2028.
The growing awareness regarding the importance of animal health and welfare has led to increased investments in veterinary pharmaceutical research and development. This awareness is driven by the rising concern for the well-being of pets, livestock, and animals usedโฆ
Global Contract Research Organization (CRO) Services Market
According to a new market research report published by Global Market Estimates, the Global Contract Research Organization (CRO) Services Market is expected to grow at a CAGR of 10.2% from 2023 to 2028.
The growth of the contract research organization (CRO) Services Market is fuelled by factors including the rising preference for outsourcing clinical trials, increasing investments in research and development by pharmaceutical and biopharmaceutical companies, the growing complexities in drugโฆ
Contract Research Organization (CRO) Services Market - Efficiency, Expertise, Ex โฆ
Newark, New Castle, USA: The "Contract Research Organization (CRO) Services Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Contract Research Organization (CRO) Services Market: https://www.growthplusreports.com/report/contract-research-organization-cro-services-market/7630
This latest reportโฆ
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercialโฆ
Pracedo Promote Ellie Copp To CRO
Pracedo, a Mashfrog Group company that provides Salesforce consultancy and digital transformation to charities, NGOs, and enterprise customers, promotes Ellie Copp to Chief Revenue Officer.
Pracedo announced Ellie Copp as its new Chief Revenue Officer (CRO). Ellie joined Pracedo in 2019 and most recently held the position of Sales and Marketing Director. As CRO, she will continue to lead the commercial teams by overseeing all revenue-generating activities as Pracedo continuesโฆ
Partnership factors in sponsor โ CRO relationships
Drugs discovered today can realistically cost upwards of 900 million dollars and around 12 years of development to reach a market. CROโs have been increasingly used by larger pharma to outsource their clinical research, allowing big pharma to shut down in-house R&D, in practice saving money.
There have been some issues however with the outsourcing of trials to CROs, including serious relationship break down with negative attitudes, failure to communicateโฆ
